Target price | $6.50 |
Course | $1.10 |
Price potential |
493.61%
register free of charge
|
Number of estimates | 2 |
2 Analysts have issued a price target Iterum Therapeutics Plc 2025 .
The average Iterum Therapeutics Plc target price is $6.50.
This is
493.61%
register free of charge
$7.00
539.27%
register free of charge
$6.00
447.95%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Iterum Therapeutics Plc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Iterum Therapeutics Plc share has an average upside potential 2025 of
493.61%
register free of charge
|
Dec '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -2.96 | -1.67 |
18.46% | 43.58% | |
P/E ratio | negative |
2 Analysts have issued a Iterum Therapeutics Plc forecast for earnings per share. The average Iterum Therapeutics Plc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Iterum Therapeutics Plc...
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.